ProACT Post-Approval Study

NARecruitingINTERVENTIONAL
Enrollment

145

Participants

Timeline

Start Date

February 19, 2019

Primary Completion Date

September 1, 2025

Study Completion Date

September 1, 2030

Conditions
Stress Urinary Incontinence
Interventions
DEVICE

ProACT Adjustable Continence Therapy for Men

The ProACT therapy consists of two small, adjustable silicone balloons connected with tubing to a port. During a minimally invasive outpatient procedure, the balloons are surgically placed in the area where the prostate was removed or resected.

Trial Locations (6)

30322

RECRUITING

Emory University, Atlanta

32610

RECRUITING

University of Florida, Gainesville

48109

RECRUITING

University of Michigan, Ann Arbor

56303

RECRUITING

CentraCare- St. Cloud, Saint Cloud

66103

RECRUITING

University of Kansas Medical Center, Kansas City

80045

RECRUITING

University of Colorado, Denver

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Uromedica

INDUSTRY

NCT03767595 - ProACT Post-Approval Study | Biotech Hunter | Biotech Hunter